Research progress of exosomes in drug resistance of breast cancer

Lihui Liu,Daqing Jiang,Shi Bai,Xinfeng Zhang,Yue Kang

DOI: https://doi.org/10.3389/fbioe.2023.1214648

IF: 5.7

2024-01-04

Frontiers in Bioengineering and Biotechnology

Abstract:Since breast cancer is a heterogeneous disease, there are currently a variety of treatment methods available, including chemotherapy, endocrine therapy, molecular targeted therapy, immunotherapy, radiation therapy, etc. Breast cancer recurrence and metastasis, despite many treatment modalities, constitute a considerable threat to patients' survival time and pose a clinical challenge that is difficult to tackle precisely. Exosomes have a very special and crucial role in the treatment of drug resistance in breast cancer as a carrier of intercellular communication in the tumor microenvironment. Exosomes and breast cancer treatment resistance have been linked in a growing number of clinical investigations in recent years. This paper covers the status of research on exosomes in the treatment of breast cancer drug resistance and offers theoretical guidance for investigating new strategies to treat breast cancer drug resistance.

multidisciplinary sciences